Abbott's Amplatzer Amulet provided superior left atrial appendage (LAA) closure over the old-guard Watchman (Boston Scientific) device but failed to significantly cut stroke or bleeding rates in ...
Women have more in-hospital complications than men and double the risk for major adverse events after left atrial appendage occlusion (LAAO) with the Watchman device, according to new National ...
ABBOTT PARK, Ill., Aug. 30, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from the Amuletâ„¢ LAA Occluder IDE trial, a multi-center, head-to-head study comparing the company ...
Two newly published studies shed light on how real-world patients with atrial fibrillation fared after undergoing left atrial appendage occlusion (LAAO) with the first-generation Watchman device ...
Please provide your email address to receive an email when new articles are posted on . In a head-to-head trial of the Amplatzer Amulet and Watchman FLX left atrial appendage closure devices, the ...
In the first 3 years of the LAAO Registry, the Watchman left atrial appendage (LAA) closure device (Boston Scientific) was implanted with rates of in-hospital safety outcomes that were comparable to ...
17 deaths and 120 serious injuries have been reported due to complications during Watchman procedures. Boston Scientific warned Watchman customers of a higher risk of complications during procedures ...
In the showdown between left atrial appendage (LAA) closure devices, the Amplatzer Amulet outperformed Watchman for peridevice leaks (PDL) in one trial longer term but not in another. At 12 months of ...
After the FDA said last year it would keep a closer eye on the potential complications of a type of permanent heart plug designed to cut the risk of stroke, Boston Scientific has put forward ...
Please provide your email address to receive an email when new articles are posted on . In a head-to-head comparison of two left atrial appendage closure devices for patients with atrial fibrillation, ...
SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure ...
More than five million Americans have atrial fibrillation (AF), a common heart condition where the upper chambers of the heart (atria) beat too fast and with chaotic rhythm (fibrillation). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results